首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >Na/K citrate versus sodium bicarbonate in prevention of contrast-induced nephropathy
【24h】

Na/K citrate versus sodium bicarbonate in prevention of contrast-induced nephropathy

机译:柠檬酸钠/碳酸氢钠与碳酸氢钠预防对比剂诱发的肾病

获取原文
获取外文期刊封面目录资料

摘要

Contrast-induced nephropathy (CIN) is one of the important complications of radiographic procedures, especially in patients with chronic kidney disease. It is also one of the common causes of acute kidney injury. The pathogenesis is postulated to be the effect of oxygen- free radicals and hyperosmolar stress on the renal medulla. It is reported that the production of superoxide is most active at acid environment. K/Na citrate is well known as a urine alkalini- zation medium, and this has been evaluated earlier with standard hydration for reduction of CIN and was stated to be efficient. We aimed to determine the efficacy of Na/K citrate in reducing the frequency of CIN in comparison to sodium bicarbonate in patients after coronary angiography. Two hundred and ten patients with renal dysfunction [estimated glomerular filtration rate (eGFR), 60 mL/min/1.73 m2or less] who underwent elective or emergency coronary angiography (CAG) with/without percutaneous coronary intervention (PCI) at our institution were enrolled into the study. The patients were randomized into two groups, Group 1-Taking Na/K citrate and Group 2-Taking sodium bicarbonate. Radiographic contrast agent iohexol was used. Change in creatinine, percent change in creatinine, percent change in eGFR, change in serum potassium, and urine pH were all compared between the two groups. There was no significant difference for prevention of CIN when comparing the Na/K citrate with sodium bicarbonate solution in patients exposed to CAG with or without PCI. Mean absolute change in eGFR after 48 h after administration of contrast between sodium bicarbonate group and Na/K citrate group was ?0.60 ± 1.58 versus ?0.71 ± 1.38. Serum potassium decreased postprocedure in the sodium bicarbonate group than in the citrate group (3.90 ± 0.33 vs. 4.14 ± 0.39). Both agents are equally effective in reducing the incidence of CIN, but the citrate would possibly be a safer option for patients at risk of hypokalemia.
机译:造影剂引起的肾病(CIN)是射线照相术的重要并发症之一,特别是在患有慢性肾脏疾病的患者中。它也是急性肾损伤的常见原因之一。推测其发病机制是氧自由基和高渗应激对肾髓质的影响。据报道,超氧化物的产生在酸性环境下最活跃。柠檬酸钾/钠是众所周知的尿液碱化介质,它已经通过标准水合作用进行了较早的评估以降低CIN,并被认为是有效的。我们旨在确定与碳酸氢钠相比,冠状动脉造影术后患者使用柠檬酸钠/柠檬酸降低CIN频率的功效。肾功能不全[肾小球滤过率(eGFR)估计为60 mL / min / 1.73 m 2

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号